Nuclear Radiology: Page 13

New PET/CT tracer reliably detects prostate cancer

By Wayne Forrest

Nuclear medicine departments now have a second reliable radiopharmaceutical to consider with PET/CT when staging for prostate cancer, according to a study in the April issue of the Journal of Nuclear Medicine.

May 12, 2020

Nuclear medicine guidelines promote COVID-19 safety

By Wayne Forrest

How can nuclear medicine departments keep patients and staff safe during the COVID-19 pandemic? A new set of guidelines from the International Atomic Energy Agency (IAEA) provides some guidance.

April 26, 2020

How can nuclear medicine help with COVID-19 pandemic?

By Wayne Forrest

Radiology departments have been working overtime since the outbreak of COVID-19. But how nuclear medicine can contribute to the healthcare of the world's populations remains somewhat unclear, according to an article published online April 7 in Nuklearmedizin.

April 9, 2020

Incidental COVID-19 findings seen on routine FDG-PET/CT

By Wayne Forrest

Nuclear medicine practitioners should be prepared for incidental findings of COVID-19 when patients undergo FDG-PET/CT scans for routine oncologic indications, according to a study published online April 1 in the Journal of Nuclear Medicine.

April 2, 2020

Wuhan nuclear medicine docs give COVID-19 safety advice

By Wayne Forrest

Nuclear medicine specialists from Wuhan, China, the epicenter of the COVID-19 outbreak, have published safety precautions for dealing with patients, staff, and equipment during the pandemic in a March 25 article in the European Journal of Nuclear Medicine and Molecular Imaging.

March 30, 2020

IAEA publishes SPECT/CT usage guide

By AuntMinnie.com staff writers

The International Atomic Energy Agency (IAEA) has published a quality control guide for SPECT/CT for nuclear medicine physicists, specialists, and radiation technologists.

March 29, 2020

Curium acquires Zevacor Molecular

By AuntMinnie.com staff writers

Nuclear medicine firm Curium Pharma has acquired radiopharmaceutical developer Zevacor Molecular in a deal aimed at strengthening its PET portfolio.

March 2, 2020

Cu-64 DOTATATE PET could handle neuroendocrine tumors

By Wayne Forrest

PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine.

January 14, 2020

RadioMedix, Curium file NDA for PET agent

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and global nuclear medicine firm Curium have filed a new drug application (NDA) with the U.S. Food and Drug Administration for the firms' PET diagnostic radiopharmaceutical copper-64 (Cu-64) DOTATATE.

January 7, 2020

PET and prejudice: Insurance firms' misconceptions

By Wayne Forrest

Healthcare insurance companies should value PET imaging and its cost-effective contributions to patient outcomes rather than view the modality as too expensive and unworthy of reimbursement, according to an editorial in the December issue of the Journal of Nuclear Medicine.

December 9, 2019

PSMA-PET agent could aid prostate cancer patients

By AuntMinnie.com staff writers

Japanese and German researchers are reporting early success with a PET imaging agent that could both diagnose and treat patents with prostate cancer, according to a preclinical study published in the November issue of the Journal of Nuclear Medicine.

November 17, 2019

Philips recalls gamma camera due to risk of head failure

By AuntMinnie.com staff writers

Philips Healthcare is recalling its Forte gamma cameras due to the risk that one of the system's detector heads could become detached and injure patients, according to the U.S. Food and Drug Administration. No injuries have been reported.

November 4, 2019

Previous Page

Page 13 of 81

Next Page